Could a second blood thinner slash stroke risk? new trial investigates
NCT ID NCT07237308
First seen Nov 19, 2025 · Last updated May 12, 2026 · Updated 28 times
Summary
This study compares two treatments to prevent another stroke in people who have both atrial fibrillation (an irregular heartbeat) and hardened brain arteries. About 586 participants will receive either the blood thinner apixaban alone or apixaban plus clopidogrel for 30 days. The goal is to see if the combination reduces new stroke spots on brain scans better than apixaban alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.